This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1980 Mar 13;284(5752):118-20.

doi: 10.1038/284118a0.

Drug innovation--what's slowing it down?

F Steward, G Wibberley

PMID: 7360238
DOI: 10.1038/284118a0

Drug innovation--what's slowing it down?

F Steward et al. Nature. 1980.

. 1980 Mar 13;284(5752):118-20.

doi: 10.1038/284118a0.

Authors

F Steward, G Wibberley

PMID: 7360238
DOI: 10.1038/284118a0

No abstract available

PubMed Disclaimer

Similar articles

Are the drug-regulatory agencies paper villains?
Smith T. Smith T. Br Med J. 1980 Nov 15;281(6251):1333-5. doi: 10.1136/bmj.281.6251.1333. Br Med J. 1980. PMID: 7002251 Free PMC article. Clinical Trial. No abstract available.
Limitations on the discovery and supply of medicines.
Weatherall M. Weatherall M. Proc R Soc Med. 1974 Dec;67(12 Pt 2):1287-92. doi: 10.1177/003591577406712P205. Proc R Soc Med. 1974. PMID: 4449879 Free PMC article. No abstract available.
Washington Report. Drug Regulation Reform.
Greenberg DS. Greenberg DS. N Engl J Med. 1978 Apr 27;298(17):979-80. doi: 10.1056/NEJM197804272981726. N Engl J Med. 1978. PMID: 642986 No abstract available.
Development of new drugs in man: a review.
Davies IB, Grind IM, Pottage A, Turner P. Davies IB, et al. J R Soc Med. 1986 Feb;79(2):96-9. doi: 10.1177/014107688607900210. J R Soc Med. 1986. PMID: 3512825 Free PMC article. Review. No abstract available.
Drug development: risks and problems.
Azarnoff DL, Herting RL. Azarnoff DL, et al. Ann N Y Acad Sci. 1984;432:279-85. doi: 10.1111/j.1749-6632.1984.tb14527.x. Ann N Y Acad Sci. 1984. PMID: 6395765 Review. No abstract available.

See all similar articles

Cited by

Predictive validity in drug discovery: what it is, why it matters and how to improve it.
Scannell JW, Bosley J, Hickman JA, Dawson GR, Truebel H, Ferreira GS, Richards D, Treherne JM. Scannell JW, et al. Nat Rev Drug Discov. 2022 Dec;21(12):915-931. doi: 10.1038/s41573-022-00552-x. Epub 2022 Oct 4. Nat Rev Drug Discov. 2022. PMID: 36195754 Review.
The drug industry: the goose that lays the golden drugs.
Smith T. Smith T. Br Med J. 1980 Nov 8;281(6250):1255-7. doi: 10.1136/bmj.281.6250.1255. Br Med J. 1980. PMID: 7427658 Free PMC article. No abstract available.
Trends in the development of new medicines by UK-owned pharmaceutical companies (1964-1980).
Prentis RA, Walker SR. Prentis RA, et al. Br J Clin Pharmacol. 1986 Apr;21(4):437-43. doi: 10.1111/j.1365-2125.1986.tb05219.x. Br J Clin Pharmacol. 1986. PMID: 3518774 Free PMC article.
The regulatory control of non-steroidal anti-inflammatory agents.
Dukes MN, Lunde I. Dukes MN, et al. Eur J Clin Pharmacol. 1981 Jan;19(1):3-10. doi: 10.1007/BF00558371. Eur J Clin Pharmacol. 1981. PMID: 7461020
Novel medicines marketed in the UK (1960-87).
Lis Y, Walker SR. Lis Y, et al. Br J Clin Pharmacol. 1989 Sep;28(3):333-43. doi: 10.1111/j.1365-2125.1989.tb05435.x. Br J Clin Pharmacol. 1989. PMID: 2789928 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group